Search

everythinglearnresearchcommunity

for

Search:↓

The drug combination was safe and showed promise in treating advanced tumors.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

FDG PET/CT scans can change cancer treatment plans for dogs.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Gray hair can potentially be reversed, leading to new treatments.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Platelet-rich plasma treatment is more effective and cost-efficient than epinephrine for healing bleeding peptic ulcers, with fewer complications and rebleeding cases.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.